Close

Allergan (AGN) to Present IBS Portfolio Data at ACG Annual Meeting

Go back to Allergan (AGN) to Present IBS Portfolio Data at ACG Annual Meeting

Allergan Demonstrates Continued Commitment to Irritable Bowel Syndrome with Diarrhea Management with Two Poster Presentations at ACG 2016

October 14, 2016 8:00 AM EDT

DUBLIN, Oct. 14, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company committed to the research and development of new treatments for gastrointestinal diseases, today announced that new data from its irritable bowel syndrome portfolio will be featured in two poster presentations at the upcoming American College of Gastroenterology (ACG) Annual Scientific Meeting in Las Vegas, NV, October 14-19, 2016. 

Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO

The scheduled... More